# Oil-Dri Corp of America: Form 10-Q for the period ended Apr 30, 2017

- Company: [Oil-Dri Corp of America](/companies/odc.md) (CIK 74046)
- Form: 10-Q
- Filed: 2017-06-07
- Accepted by EDGAR: Jun 7, 2017, 16:05 ET
- Period: 2017-04-30
- Accession: 0000074046-17-000028
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/74046/000007404617000028/odc10-q04302017.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/74046/000007404617000028/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-04-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2017-02-01 to 2017-04-30 | $64.7m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months, 2016-08-01 to 2017-04-30 | $196.5m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2017-02-01 to 2017-04-30 | $47.0m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2016-08-01 to 2017-04-30 | $138.9m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2017-02-01 to 2017-04-30 | $17.8m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2016-08-01 to 2017-04-30 | $57.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2017-02-01 to 2017-04-30 | $14.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2016-08-01 to 2017-04-30 | $45.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-02-01 to 2017-04-30 | $3.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2016-08-01 to 2017-04-30 | $12.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2017-02-01 to 2017-04-30 | $557.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2016-08-01 to 2017-04-30 | $2.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-02-01 to 2017-04-30 | $3.2m | us-gaap:ProfitLoss |
| Net income | 9 months, 2016-08-01 to 2017-04-30 | $9.5m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2017-02-01 to 2017-04-30 | $0.44 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2016-08-01 to 2017-04-30 | $1.29 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months, 2017-02-01 to 2017-04-30 | 7,164,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2016-08-01 to 2017-04-30 | 7,151,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2016-08-01 to 2017-04-30 | $21.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2016-08-01 to 2017-04-30 | $10.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2016-08-01 to 2017-04-30 | $4.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2016-08-01 to 2017-04-30 | $135.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-04-30 | $13.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-04-30 | $98.1m | us-gaap:AssetsCurrent |
| Total assets | at 2017-04-30 | $212.1m | us-gaap:Assets |
| Current liabilities | at 2017-04-30 | $32.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-04-30 | $89.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-04-30 | $122.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 32,928 characters.

*The following discussion and analysis of our financial condition and results of operations should be read together with the financial statements and the related notes included herein and our Consolidated Financial Statements, accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended July 31, 2016. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed under “Forward-Looking Statements” and Item 1A, Risk Factors, of our Annual Report on Form 10-K for the fiscal year ended July 31, 2016.*

### OVERVIEW

We develop, mine, manufacture and market sorbent products principally produced from clay minerals and, to a lesser extent, other clay-like sorbent materials. Our principal products include agricultural and horticultural chemical carriers, animal health and nutrition products, bleaching clay and fluid purification aids, cat litter, industrial and automotive floor absorbents and sports field products. Our products are sold to two primary customer groups, including customers who resell our products as originally produced to the end consumer and those who use our products as part of their production process or use them as an ingredient in their final finished product. We have two reportable operating segments based on the different characteristics of our two primary customer groups: Retail and Wholesale Products Group and Business to Business Products Group, as described in Note 7 of the notes to the Condensed Consolidated Financial Statements.

### RESULTS OF OPERATIONS

### NINE MONTHS ENDED APRIL 30, 2017 COMPARED TO

### NINE MONTHS ENDED APRIL 30, 2016

CONSOLIDATED RESULTS

Consolidated net sales for the nine months ended April 30, 2017 were $196,531,000, compared to net sales of $197,397,000 for the nine months ended April 30, 2016. Net sales were down for our Retail and Wholesale Products Group, but were up for our Business to Business Products Group. Consolidated net income for the first nine months of fiscal 2017 was $9,470,000, a 13% increase from net income of $8,352,000 for the first nine months of fiscal 2016. Both segments reported higher operating income, as described further below. Diluted net income per share was $1.29 for the first nine months of fiscal 2017, compared to $1.15 for the first nine months of fiscal 2016.

Consolidated gross profit as a percentage of net sales for the first nine months of fiscal 2017 was 29%, compared to 30% for the first nine months of fiscal 2016. Gross profit in fiscal 2017 was negatively impacted by the cost of natural gas used to operate kilns that dry our clay. The cost of natural gas per manufactured ton was approximately 27% higher than the prior year. Other manufacturing costs per ton produced were up approximately 6% compared to the same period in the prior fiscal year, including higher expenses for employee benefits, depreciation, wages, repairs and salaries. Gross profit was positively impacted by approximately 3% lower packaging costs per manufactured ton. A significant amount of our packaging purchases are subject to contractual price adjustments throughout the year based on underlying commodity prices. Prices for commodities may fluctuate considerably, particularly commodities related to our resin and paper-based packaging. The lower packaging costs reflected favorable commodity prices at the time of the most recent price adjustment.

Total selling, general and administrative expenses were 2% lower for the first nine months of fiscal 2017 compared to the first nine months of fiscal 2016. The decrease was driven by lower advertising expense in the Retail and Wholesale Products Group. The discussion of the segments' operating incomes below describe the changes in the selling, general and administrative expenses that were allocated to the operating segments. The remaining unallocated corporate expenses in the first nine months of fiscal 2017 included increased pension expense and additional costs related to the implementation of our new enterprise resource planning software. These higher corporate expenses were partially offset by a lower estimated annual incentive bonus accrual compared to the prior year. The incentive bonus accruals were based on performance targets established for each fiscal year.

Tax expense was 19% of pre-tax income for the first nine months of fiscal 2017, compared to 27% for the first nine months of fiscal 2016. Our effective tax rate was based on the estimated level of our taxable income for the year and the assessment of various deductions, including depletion. The lower fiscal 2017 effective tax rate resulted from an estimated depletion deduction which was a greater percentage of pre-tax income compared to fiscal 2016.

BUSINESS TO BUSINESS PRODUCTS GROUP

Net sales of the Business to Business Products Group for the first nine months of fiscal 2017 were $74,893,000, an increase of $3,974,000, or 6%, from net sales of $70,919,000 for the first nine months of fiscal 2016. Net sales of our animal health and nutrition products increased approximately 19%. Sales were higher in domestic and most foreign markets, particularly in Asia. In Latin America, the transition to a new distributor negatively impacted sales. Sales for the first nine months of fiscal 2017 also included customer trials of our new Varium poultry growth promoter. See “Foreign Operations” below for further discussion of increased animal health and nutrition sales by our subsidiary in China. Net sales of our fluids purification products were up approximately 9%. Sales to edible oil producers accounted for much of the sales improvement, which included sales to a new customer in Europe added in the fourth quarter of fiscal 2016. Lower sales from normal ordering fluctuations of customers in the petroleum oil processing industry partially offset this increase. Net sales of our agricultural chemical carrier products were essentially flat compared to the first nine months of the prior year. Sales of our co-packaged coarse cat litter were approximately 8% lower due to fewer tons sold and a price adjustment under our co-packaging agreement.

Selling, general and administrative expenses for the Business to Business Products Group were approximately 2% lower due primarily to lower costs to promote our animal health and nutrition products.

The Business to Business Products Group’s operating income for the first nine months of fiscal 2017 was $25,033,000, an increase of $984,000, or 4%, from operating income of $24,049,000 for the first nine months of fiscal 2016. The benefits of higher sales and lower packaging costs more than offset higher natural gas and other manufacturing costs. See “Consolidated Results” above for further discussion of packaging, natural gas and manufacturing costs.

RETAIL AND WHOLESALE PRODUCTS GROUP

Net sales of the Retail and Wholesale Products Group for the first nine months of fiscal 2017 were $121,638,000, a decrease of $4,840,000, or 4%, from net sales of $126,478,000 for the first nine months of fiscal 2016. Total cat litter net sales declined approximately 5% compared to the first nine months of the prior year. Lower sales of both our branded and private label cat litters was largely attributed to the decision to exit low margin business with two major customers. Through the first nine months we continued our integrated marketing campaign to generate awareness and trial of lightweight cat litter products, although we spent significantly less for advertising in the third quarter of fiscal 2017 compared to the third quarter of fiscal 2016. Our promotional efforts delivered higher sales of both our Cat's Pride Fresh & Light Ultimate Care and our private label lightweight scoopable litters for the first nine months of fiscal 2017.

Sales of industrial and automotive absorbent products were essentially flat compared to the first nine months of fiscal 2016. Nine month sales for our subsidiary in Canada were higher than the prior year, while sales for our subsidiary in the United Kingdom were lower. See “Foreign Operations” below for further discussion about the sales and types of products sold by these foreign subsidiaries.

Selling, general and administrative expenses for the Retail and Wholesale Products Group were 9% lower compared to the first nine months of fiscal 2016. Advertising expense decreased approximately $1,400,000 due to lower expenditures for the integrated marketing campaign to promote our Fresh & Light Ultimate Care lightweight cat litter, which began in the second quarter of fiscal 2016. We expect to continue promoting lightweight litter through the remainder of fiscal 2017. However, we plan to reallocate some of our anticipated spending between advertising, which is included in selling, general and administrative expenses, and trade promotions, which are included as a reduction of net sales. Although we expect advertising expense will be significant for the full year of fiscal 2017, the total is anticipated to be down from the corresponding expense in fiscal 2016.

The Retail and Wholesale Products Group's operating income for the first nine months of fiscal 2017 was $5,996,000, an increase of $314,000, or 6%, from operating income of $5,682,000 for the first nine months of fiscal 2016. The reduction in advertising costs, as discussed above, more than offset higher natural gas and other manufacturing costs. See “Consolidated Results” above for further discussion of packaging, natural gas and manufacturing costs.

FOREIGN OPERATIONS

Foreign operations include our subsidiaries in Canada and the United Kingdom, which are included in the Retail and Wholesale Products Group, and our subsidiary in China, which is included in the Business to Business Products Group. Net sales by our foreign subsidiaries during the first nine months of fiscal 2017 were $9,344,000, a 13% increase compared to net sales of $8,270,000 during the first nine months of fiscal 2016. Our subsidiary in China reported higher sales for animal health and nutrition products with approximately 29% more tons sold, including sales to new customers. Sales by our subsidiary in Canada increased for branded and private label lightweight cat litter. In addition, a new Canadian distributor provided increased sales of industrial absorbent products. These increases were partially offset by lower export sales of fluids purification products sold by our subsidiary in the United Kingdom. Net sales by our foreign subsidiaries represented 5% and 4% of our consolidated net sales during the first nine months of fiscal years 2017 and 2016, respectively.

Our foreign subsidiaries reported a net loss of $41,000 for the first nine months of fiscal 2017 compared to a net loss of $750,000 for the first nine months of fiscal 2016. The improved profitability was driven primarily by the higher sales.

Identifiable assets of our foreign subsidiaries as of April 30, 2017 were $7,719,000, compared to $8,017,000 as of April 30, 2016. The decrease was due primarily to lower net fixed assets, deferred income taxes and accounts receivable, which were partially offset by higher inventories.

### THREE MONTHS ENDED APRIL 30, 2017 COMPARED TO

### THREE MONTHS ENDED APRIL 30, 2016

CONSOLIDATED RESULTS

Consolidated net sales for the three months ended April 30, 2017 were $64,745,000, compared to net sales of $64,235,000 for the three months ended April 30, 2016. Net sales were up for our Business to Business Products Group, but were down for our Retail and Wholesale Products Group. Consolidated net income was $3,211,000 for the third quarter of fiscal 2017, compared to a net loss of $892,000 for the third quarter of fiscal 2016. Third quarter operating income increased for both our Business to Business Products and Retail and Wholesale Products Groups compared to the prior year. Significantly lower advertising expense in the quarter, as described below, drove improvements in both consolidated net income and the Retail and Wholesale Products Group's operating income. Diluted net income per share was $0.44 for the third quarter of fiscal 2017, compared to a diluted net loss per share of $0.13 for the third quarter of fiscal 2016.

Consolidated gross profit as a percentage of net sales for the third quarter of fiscal 2017 was 27%, compared to 29% for the third quarter of fiscal 2016. Higher natural gas and other manufacturing costs more than offset lower freight costs in the third quarter of fiscal 2017. The cost per manufactured ton for natural gas used to operate kilns that dry our clay increased approximately 54%. Other manufacturing costs per ton produced were up approximately 7%, including higher expenses for wages, benefits, repairs and depreciation. Packaging costs were essentially flat compared to the third quarter of the prior fiscal year.

Total selling, general and administrative expenses were 29% lower for the third quarter of fiscal 2017 compared to the third quarter of fiscal 2016. The discussion of the segments' operating incomes below describe the selling, general and administrative expenses allocated to the operating segments, particularly lower advertising expense in the Retail and Wholesale Products Group. The remaining unallocated corporate expenses in the third quarter of fiscal 2017 included increased pension expense and a higher estimated annual incentive bonus accrual, as well as additional costs related to the implementation of our new enterprise resource planning software. The incentive bonus accruals were based on performance targets established for each fiscal year.

Tax expense was 15% of pre-tax income for the third quarter of fiscal 2017, compared to 28% for the third quarter of fiscal 2016. Our effective tax rate was based on the estimated level of our taxable income for the year and the assessment of various tax deductions, including depletion. The lower fiscal 2017 effective tax rate resulted from an estimated depletion deduction which was a greater percentage of pre-tax income compared to fiscal 2016.

BUSINESS TO BUSINESS PRODUCTS GROUP

Net sales of the Business to Business Products Group for the third quarter of fiscal 2017 were $24,159,000, an increase of $1,686,000, or 8%, from net sales of $22,473,000 for the third quarter of fiscal 2016. Net sales of our fluids purification products were up approximately 13%. Sales to edible oil producers accounted for much of the sales improvement, which included sales to a new customer in Europe added in the fourth quarter of fiscal 2016. Sales of our animal health and nutrition products increased approximately 11% across domestic and foreign markets. Third quarter sales included customer trials of our new Varium poultry growth promoter. See “Foreign Operations” below for further discussion of increased animal health and nutrition sales by our subsidiary in China. Net sales of our agricultural chemical carriers to manufacturers of crop protection products were up slightly compared to the third quarter of the prior year. Sales of co-packaged coarse cat litter were approximately 4% lower than in the third quarter of fiscal 2016 due to fewer tons sold and a price adjustment under our co-packaging agreement.

Selling, general and administrative expenses for the Business to Business Products Group were 3% lower due primarily to lower costs to promote our animal health and nutrition products and collection of a previously reserved account receivable.

The Business to Business Products Group’s operating income for the third quarter of fiscal 2017 was $7,810,000, an increase of $506,000, or 7%, from operating income of $7,304,000 in the third quarter of fiscal 2016. The benefits of higher sales and lower selling, general and administrative expenses more than offset increased natural gas and other manufacturing costs. See “Consolidated Results” above for further discussion of manufacturing and packaging costs.

RETAIL AND WHOLESALE PRODUCTS GROUP

Net sales of the Retail and Wholesale Products Group for the third quarter of fiscal 2017 were $40,586,000, a decrease of $1,176,000, or 3%, from net sales of $41,762,000 for the third quarter of fiscal 2016. Total cat litter net sales declined approximately 4% compared to the third quarter of the prior year. Significantly less spending for advertising compared to the third quarter of fiscal 2016 contributed to lower branded scoopable litter sales; however, higher sales of our private label lightweight litters partially offset the decline. Lower sales of both our private label and branded coarse litters for the third quarter of fiscal 2017 compared to the prior year reflected the decline of this segment of the market.

Sales of sports products were up approximately 5% compared to the third quarter of fiscal 2016 due to higher volume. Sales of industrial and automotive absorbent products for the quarter were essentially the same as the prior year. Third quarter sales for our subsidiaries in both Canada and the United Kingdom were higher than the prior year. See “Foreign Operations” below for further discussion about the sales and types of products sold by these foreign subsidiaries.

Selling, general and administrative expenses for the Retail and Wholesale Products Group were 52% lower compared to the third quarter of fiscal 2016. The decrease was driven by approximately $6,400,000 lower advertising expense for our integrated marketing campaign to promote our Fresh & Light Ultimate Care lightweight cat litter, which began in the second quarter of fiscal 2016. We expect to continue promoting lightweight litter through the remainder of fiscal 2017. However, we plan to reallocate some of our anticipated spending between advertising, which is included in selling, general and administrative expenses, and trade promotions, which are included as a reduction of net sales. Although we expect advertising expense will be significant for the full year of fiscal 2017, the total is anticipated to be down from the corresponding expense in fiscal 2016.

The Retail and Wholesale Products Group's operating income for the third quarter of fiscal 2017 was $1,516,000, compared to an operating loss of $4,015,000 for the third quarter of fiscal 2016. The increase in operating income was driven by the lower advertising costs discussed above. The reduction in advertising costs more than offset higher natural gas and other manufacturing costs. See “Consolidated Results” above for further discussion of these cost changes.

FOREIGN OPERATIONS

Foreign operations include our subsidiaries in Canada and the United Kingdom, which are included in the Retail and Wholesale Products Group, and our subsidiary in China, which is included in the Business to Business Products Group. Net sales by our foreign subsidiaries during the third quarter of fiscal 2017 were $2,869,000, a 5% increase compared to net sales of $2,738,000 in the third quarter of fiscal 2016. Our subsidiary in China reported higher sales for animal health and nutrition products with approximately 4% more tons sold, including sales to new customers. Sales also increased for industrial absorbent products sold by our subsidiary in Canada, due primarily to a new distributor, and for export and domestic sales of fluids purification products by our subsidiary in the United Kingdom. Net sales by our foreign subsidiaries represented approximately 4% of our consolidated net sales during the third quarters of both fiscal 2017 and 2016.

Our foreign subsidiaries reported a net loss of $339,000 for the third quarter of fiscal 2017 compared to a net loss of $214,000 for the third quarter of fiscal 2016.

### LIQUIDITY AND CAPITAL RESOURCES

Our principal capital requirements include: funding working capital needs; purchasing and upgrading equipment, facilities, information systems and real estate; supporting new product development; investing in infrastructure; repurchasing Common Stock; paying dividends; and business acquisitions. During the first nine months of fiscal 2017, we principally used cash generated from operations to fund these requirements. We also have the ability to borrow under our revolving credit agreement with BMO Harris Bank N.A. (“BMO Harris”), as described further below, however we have not borrowed under the credit agreement in recent years. Cash and cash equivalents decreased $5,026,000 during the first nine months of fiscal 2017 to $13,603,000; however, short term investments increased $8,516,000 during the same period to $18,700,000 as of April 30, 2017.

The following table sets forth certain elements of our Condensed Consolidated Statements of Cash Flows (in thousands):

|  | For the Nine Months Ended April 30, 2017 | 2016 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$21,033** | $19,409 |
| Net cash used in investing activities | **(18,858)** | (15,093) |
| Net cash used in financing activities | **(7,261)** | (7,343) |
| Effect of exchange rate changes on cash and cash equivalents | **60** | 83 |
| Net decrease in cash and cash equivalents | **$(5,026)** | $(2,944) |

#### Net cash provided by operating activities

In addition to net income, as adjusted for depreciation and amortization and other non-cash operating activities, the primary sources and uses of operating cash flows for the first nine months of fiscal years 2017 and 2016 were as follows:

Accounts receivable, less allowance for doubtful accounts, increased $1,633,000 in the first nine months of fiscal 2017 compared to a decrease of $2,289,000 in the first nine months of fiscal 2016. The change in accounts receivable balances reflected differences in the level and timing of sales and collections, as well as the payment terms provided to various customers.

Inventories increased $617,000 in the first nine months of fiscal 2017 compared to an increase of $3,653,000 in the first nine months of fiscal 2016. The substantial increase in fiscal 2016 was due to anticipated sales following the launch of our integrated marketing campaign to promote our Fresh & Light Ultimate Care lightweight cat litter.

Prepaid expenses increased $1,171,000 in the first nine months of fiscal 2017 compared to an increase of $593,000 in the first nine months of fiscal 2016. The increase in the first nine months of fiscal 2017 was due primarily to higher prepaid advertising expenses. Prepaid income taxes drove of the increase in the first nine months of fiscal 2016. Prepayments of annual insurance premiums in both fiscal years contributed to the increase in both fiscal years to a lesser extent.

Other assets increased $669,000 in the first nine months of fiscal 2017 compared to an increase of $270,000 in the first nine months of fiscal 2016. The increase in fiscal 2017 included prepayments for long-term computer software licenses. The cash surrender value of life insurance on former key employees increased in the first nine months of both fiscal years.

Accounts payable increased $1,848,000 in the first nine months of fiscal 2017 compared to a decrease of $1,383,000 in the first nine months of fiscal 2016. Trade and freight payable varied in both periods due to timing of payments, fluctuations in the cost of goods and services we purchased, production volume levels and vendor payment terms. In addition, we performed a review of our vendor payment terms in fiscal 2017 and adjusted the timing of our payments accordingly. Current accrued estimated income taxes are also included in accounts payable balances.

Accrued expenses increased $627,000 in the first nine months of fiscal 2017 compared to an increase of $3,365,000 in the first nine months of fiscal 2016. The payout of the prior fiscal year's discretionary incentive bonus drove lower accrued salaries in the first nine months of fiscal 2017, while the increase in the first nine months of fiscal 2016 was driven by a higher incentive bonus accrual. Accrued plant expenses fluctuated in the first nine months of both fiscal years due to timing of payments, changes in the cost of goods and services we purchased, production volume levels and vendor payment terms. In addition, accrued trade promotions and advertising varied due to the timing of marketing programs.

Accrued pension and postretirement benefits increased $1,133,000 in the first nine months of fiscal 2017 compared to an increase of $757,000 in the first nine months of fiscal 2016. The trend of a lower discount rate used to estimate the value of these accrued benefits resulted in higher liabilities. See Note 6 of the notes to the unaudited Condensed Consolidated Financial Statements for further information.

#### Net cash used in investing activities

Cash used in investing activities was $18,858,000 in the first nine months of fiscal 2017 compared to cash used in investing activities of $15,093,000 in the first nine months of fiscal 2016. Cash used for capital expenditures was $10,418,000 and $7,052,000 in the first nine months of fiscal 2017 and 2016, respectively. Capital expenditures in the first nine months of fiscal 2017 included additional spending for the enterprise resource planning system implementation project and related infrastructure improvements. Net purchases of short-term investments used cash of $8,500,000 and $8,297,000 in the first nine months of fiscal 2017 and 2016, respectively. Purchases and dispositions of investment securities in both periods are impacted by variations in the timing of investment maturities, the operating cash needs of the Company and the availability of investment options.

#### Net cash used in financing activities

Cash used in financing activities was $7,261,000 in the first nine months of fiscal 2017 compared to cash used in financing activities of $7,343,000 in the first nine months of fiscal 2016. Scheduled payments on long-term debt were $3,083,000 and $3,484,000 in the first nine months of fiscal 2017 and 2016, respectively. Dividend payments in the first nine months of fiscal 2017 were $4,441,000 compared to $4,190,000 paid during the same period of fiscal 2016 due to a dividend increase.

#### Other

Total cash and investment balances held by our foreign subsidiaries of $1,454,000 as of April 30, 2017 were lower than the April 30, 2016 balances of $1,460,000. See further discussion in “Foreign Operations” above.

We have a $25,000,000 unsecured revolving credit agreement with BMO Harris which expires on December 4, 2019. The agreement also provides for a maximum of $5,000,000 for foreign letters of credit. Under the agreement we may select a variable interest rate based on either the BMO Harris prime rate or a LIBOR-based rate, plus a margin which varies depending on our debt to earnings ratio, or a fixed rate as agreed between us and BMO Harris. At April 30, 2017, the variable rates would have been 4.00% for the BMO Harris prime-based rate or 2.16% for the LIBOR-based rate. The credit agreement contains restrictive covenants that, among other things and under various conditions, limit our ability to incur additional indebtedness or to dispose of assets. The agreement also requires us to maintain a minimum fixed coverage ratio and a minimum consolidated net worth. We did not borrow under the credit agreement during the nine months ended April 30, 2017 and 2016, and we were in compliance with its covenants.

As of April 30, 2017, we had remaining authority to repurchase 301,444 shares of Common Stock under a repurchase plan approved by our Board of Directors. These repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing and amount of shares repurchased will be determined by our management.

We believe that cash flow from operations, availability under our revolving credit facility, current cash and investment balances and our ability to obtain other financing, if necessary, will provide adequate cash funds for foreseeable working capital needs, capital expenditures at existing facilities, dividend payments and debt service obligations for at least the next 12 months. We plan to continue promoting our Cat's Pride Fresh & Light Ultimate Care lightweight scoopable litter in the fourth quarter of fiscal 2017; however, we plan to reallocate some of our anticipated spending between advertising, which is included in selling, general and administrative expenses, and trade promotions, which are included as a reduction of net sales. We expect total spending for advertising and trade spending to be significant, but less than the total spent in fiscal 2016. We anticipate that our capital expenditures will increase in fiscal 2017, including spending for implementation of an enterprise resource planning software. We do not believe that these increased expenditures will dramatically impact our cash position; however our cash requirements are subject to change as business conditions warrant and opportunities arise. We continually evaluate our liquidity position and anticipated cash needs, as well as the financing options available to obtain additional cash reserves. Our ability to fund operations, to make planned capital expenditures, to make scheduled debt payments and to remain in compliance with all financial covenants under debt agreements, including, but not limited to, the current credit agreement, depends on our future operating performance, which, in turn, is subject to prevailing economic conditions and to financial, business and other factors. The timing and size of any new business ventures or acquisitions that we complete may also impact our cash requirements.

The following tables summarize our contractual obligations and commercial commitments (in thousands) as of April 30, 2017 for the time-frames indicated.

### CONTRACTUAL OBLIGATIONS AND COMMERCIAL COMMITMENTS

| Contractual Obligations | Payments Due by Period Total | Less Than 1 Year | 1 – 3 Years | 4 – 5 Years | After 5 Years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Notes Payable | $12,333 | $3,083 | $6,167 | $3,083 | $— |
| Interest on Notes Payable | 982 | 432 | 489 | 61 | — |
| Operating Leases | 14,976 | 2,102 | 2,723 | 1,541 | 8,610 |
| Total Contractual Cash Obligations | $28,291 | $5,617 | $9,379 | $4,685 | $8,610 |

24

We made total contributions to our defined benefit pension plan of $1,322,000 during the first nine months of fiscal 2017. We estimate contributions of approximately $335,000 will be made during the remainder of fiscal 2017. We have not presented this obligation for future years in the table above because the funding requirement can vary from year to year based on changes in the fair value of plan assets and actuarial assumptions. See “Item 3. Quantitative and Qualitative Disclosures About Market Risk” below for a discussion of the potential impact of financial market fluctuations on pension plan assets and future funding contributions.

|  | Amount of Commitment Expiration Per Period Total | Less Than 1 Year | 1 – 3 Years | 4 – 5 Years | After 5 Years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Other Commercial Commitments | $21,450 | $21,450 | $— | $— | $— |

The other commercial commitments in the table above represent open purchase orders, including blanket purchase orders, for items such as packaging, additives and pallets used in the normal course of operations. The expected timing of payments for these obligations is estimated based on current information. Timing of payments and actual amounts paid may be different depending on the time of receipt of goods or services, or changes to agreed-upon amounts for some obligations.

### CRITICAL ACCOUNTING POLICIES AND ESTIMATES

This discussion and analysis of financial condition and results of operations is based on our unaudited Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. GAAP for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates and assumptions are revised periodically. Actual results could differ from these estimates. See the information concerning our critical accounting policies included under “Management’s Discussion of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended July 31, 2016.

## Market risk

As filed, 3,131 characters.

We are exposed to interest rate risk and employ policies and procedures to manage our exposure to changes in the market risk of our cash equivalents and short-term investments. We believe that the market risk arising from holdings of our financial instruments is not material.

We are exposed to foreign currency fluctuation risk, primarily the U.S. Dollar relative to the British Pound, Euro, Canadian Dollar, Chinese Yuan and the Brazilian Real, as related to our foreign subsidiaries, to certain accounts receivable, and to our ability to sell in foreign markets. We are subject to translation exposure of our foreign subsidiaries’ financial statements from local currencies to U.S. Dollars. In recent years, our foreign subsidiaries have not generated a substantial portion of our consolidated sales or net income. In addition, the portion of our consolidated accounts receivable denominated in foreign currencies is not significant. Finally, foreign sales of our products may be influenced by the relative strength or weakness of the U.S. Dollar compared to various other currencies, which makes our products relatively more or less expensive than our foreign competitors' products in local marketplaces. Foreign currency fluctuations had some bearing on our operating results in the first nine months of fiscal 2017; however, historically the overall foreign currency fluctuation risk has not been material to our Consolidated Financial Statements and in the first nine months of fiscal 2017 we did not enter into any hedge contracts in an attempt to offset any adverse effect of changes in currency exchange rates.

We are exposed to market risk as it relates to the investments of plan assets under our defined benefit pension plan. The fair value of these assets is subject to change due to fluctuations in the financial markets. A lower asset value may increase our pension expense and may increase the amount of future funding contributions.

We are exposed to regulatory risk in the fluid purification, animal health and agricultural markets, principally as a result of the risk of increasing regulation of the food chain throughout the world, but particularly in the United States and Europe. We actively monitor developments in this area, both directly and through trade organizations of which we are a member.

We are exposed to commodity price risk with respect to fuel. Factors that could influence the cost of natural gas used in the kilns to dry our clay include the creditworthiness of our natural gas suppliers, the overall general economy, developments in world events, general supply and demand for natural gas, seasonality and the weather patterns throughout the United States and the world. We monitor fuel market trends and, consistent with our past practice, we may purchase fuel at spot rates on a month to month basis and we may contract for a portion of our anticipated fuel needs using forward purchase contracts to mitigate the volatility of our kiln fuel prices. As of April 30, 2017, we have not purchased any natural gas contracts for our planned kiln fuel needs for the remainder of fiscal 2017.

## Controls and procedures

As filed, 3,289 characters.

### Evaluation of Disclosure Controls and Procedures

Management conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. The controls evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”). Based upon the controls evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the fiscal quarter ended April 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

### Inherent Limitations on Effectiveness of Controls

Our management, including the CEO and CFO, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

### PART II – OTHER INFORMATION

Items 1A, 3 and 5 of this Part II are either inapplicable or are answered in the negative and are omitted pursuant to the instructions to Part II.

Filed Jun 7, 2017.
Source: SEC EDGAR, the filing index for accession 0000074046-17-000028. Last ingested by Listed: Oct 27, 2026, 16:09 ET. No prices; not investment advice.
